An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Repeat Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia. Protocol Number: ABP-19002,
Role: Investigator,
Aeon Biopharma,
(12/2022 - 12/2023)
Status: Completed
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia. Protocol Number: ABP-19000,
Role: Investigator,
Aeon Biopharma,
(06/2022 - 06/2023)
Status: Completed